|

BE.Amycon Biobank & Data Registry UZ Leuven

RECRUITINGSponsored by Universitaire Ziekenhuizen KU Leuven
Actively Recruiting
SponsorUniversitaire Ziekenhuizen KU Leuven
Started2025-09-24
Est. completion2029-09
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07172243

Summary

The goal of this study is to collect and store human body material (HBM) of patients with amyloidosis in a biobank "BE.Amycon biobank" for future research and to collect clinical data of patients with amyloidosis in a database "BE.Amycon data registry".

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Provide consent and sign informed consent form
* Age 18 years or older
* Diagnosis of amyloidosis (suspected or confirmed, any subtypes)
* For the prospective sample collection only: newly diagnosed (any subtype) or at relapse (AL amyloidosis)

Exclusion Criteria:

* Not willing to sign informed consent
* Not able to sign informed consent

Conditions5

AL AmyloidosisAmyloidosisAmyloidosis CardiacCancerHeart Disease

Browse More Trials

Cancer trialsHeart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.